Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin – a longitudinal experience from a prospectively collected database of 1108 patients

Neoadjuvant Chemotherapy Followed by Surgery versus Surgery Alone for Gastric Carcinoma: Systematic Review and Meta-Analysis of Randomized Controlled Trials

(2014) A-Man Xu et al.   PLoS One

Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma

(2014) Ming gao Guo et al.   World Journal of Surgical Oncology

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Peritoneal carcinomatosis of gastric origin: A population-based study on incidence, survival and risk factors

(2013) Irene Thomassen et al.   INTERNATIONAL JOURNAL OF CANCER

Colorectal cancer screening—optimizing current strategies and new directions

(2013) Ernst J. Kuipers et al.   Nature Reviews Clinical Oncology

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

A Proposal of a Practical and Optimal Prophylactic Strategy for Peritoneal Recurrence

(2012) Masafumi Kuramoto et al.   Journal of Oncology

Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal Carcinomatosis

(2011) D Elias et al.   ANNALS OF SURGERY

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The effectiveness of the new (7th) UICC N classification in the prognosis evaluation of gastric cancer patients: a comparative study between the 5th/6th and 7th UICC N classification

(2011) Sumin Chae et al.   Gastric Cancer

Japanese gastric cancer treatment guidelines 2010 (ver. 3)

(2011)   Gastric Cancer

Treatment of gastric cancer with peritoneal carcinomatosis by cytoreductive surgery and HIPEC: A systematic review of survival, mortality, and morbidity

(2011) Richdeep S. Gill et al.   JOURNAL OF SURGICAL ONCOLOGY

Optimizing of preoperative computed tomography for diagnosis in patients with peritoneal carcinomatosis

(2011) Carolin D Duhr et al.   World Journal of Surgical Oncology

S3-Leitlinie „Magenkarzinom” -

(2011) M. Moehler et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) A. Okines et al.   ANNALS OF ONCOLOGY

Oncologic Effectiveness of Regular Follow-up to Detect Recurrence After Curative Resection of Gastric Cancer

(2010) Bang Wool Eom et al.   ANNALS OF SURGICAL ONCOLOGY

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Benefit of Adjuvant Chemotherapy for Resectable Gastric Cancer

(2010)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Predictive Factors Improving Survival After Gastrectomy in Gastric Cancer Patients with Peritoneal Carcinomatosis

(2010) Masayoshi Hioki et al.   WORLD JOURNAL OF SURGERY

Extensive Intraoperative Peritoneal Lavage as a Standard Prophylactic Strategy for Peritoneal Recurrence in Patients with Gastric Carcinoma

(2009) Masafumi Kuramoto et al.   ANNALS OF SURGERY

Follow-Up Strategy After Curative Resection of Gastric Cancer: A Nationwide Survey in Korea

(2009) Hoon Hur et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Significance of Microscopic Positive Margins for Gastric Cancer Patients with Potentially Curative Resection

(2009) Zhe Sun et al.   ANNALS OF SURGICAL ONCOLOGY

Clinical Impact of Positive Surgical Margin Status on Gastric Cancer Patients Undergoing Gastrectomy

(2009) Shang-Yu Wang et al.   ANNALS OF SURGICAL ONCOLOGY

Factors affecting recurrence in node-negative advanced gastric cancer

(2009) Kuo-Hung Huang et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY